Corcept Therapeutics (CORT) is down -7.8%, or -$6.81 to $80.49.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORT:
- Corcept Therapeutics initiated with a Neutral at UBS
- Hold Rating for Corcept Therapeutics Amid Limited Upside and Market Challenges
- 3 ‘Strong Buy’ Stocks to Buy Today, 12/9/2025, According to Top Analysts
- 3 ‘Strong Buy’ Stocks Backed by Technical Analysis
- Corcept Therapeutics: Poised for Growth with Relacorilant’s Launch and Strong Market Positioning